EH-Domain Containing 3 (EHD3) (C-Term) Peptide
EHD3
Reactivity: Human, Rat
Host: Synthetic
BP, WB
-
- Target See all EHD3 products
- EHD3 (EH-Domain Containing 3 (EHD3))
- Protein Region
- C-Term
- Origin
- Human, Rat
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB)
- Sequence
- EGIDDAEWVV ARDKPMYDEI FYTLSPVDGK ITGANAKKEM VRSKLPNSVL
- Characteristics
- This is a synthetic peptide designed for use in combination with antiEhd3 Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
- Purification
- Purified
-
-
- Application Notes
- Optimal working dilution should be determined by the investigator.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Concentration
- 1 mg/mL
- Buffer
- Final peptide concentration is 1 mg/mL in PBS.
- Handling Advice
- Avoid repeat freeze-thaw cycles.
- Storage
- -20 °C
- Storage Comment
- For longer periods of storage, store at 20C. Avoid repeat freezethaw cycles.
-
- Target
- EHD3 (EH-Domain Containing 3 (EHD3))
- Synonyms
- PAST3 Peptide, Ehd2 Peptide, EHD3 Peptide, si:ch211-147c1.2 Peptide, MGC146452 Peptide, EH domain containing 3 Peptide, EH-domain containing 3 Peptide, EH domain containing 3 L homeolog Peptide, EHD3 Peptide, Ehd3 Peptide, ehd3 Peptide, ehd3.L Peptide
- Background
-
Mouse homolog is involved in regulating vesicular structure microtubuledependent movement.
Alias Symbols: Ehd2
Protein Size: 535 - Molecular Weight
- 58 kDa
- Gene ID
- 192249
- NCBI Accession
- NM_138890, NP_620245
- UniProt
- Q8R491
-
You are here:
